We are live on ! Find out more
BIIB icon

Biogen
BIIB

1,014 hedge funds and large institutions have $59B invested in Biogen in 2017 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 380 increasing their positions, 356 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more funds holding in top 10

Funds holding in top 10: 23 → 38 (+15)

46% more first-time investments, than exits

New positions opened: 99 | Existing positions closed: 68

16% more capital invested

Capital invested by funds: $50.9B → $59B (+$8.14B)

2% more funds holding

Funds holding: 992 → 1,014 (+22)

1.38% more ownership

Funds ownership: 87.77% → 89.15% (+1.4%)

7% more repeat investments, than reductions

Existing positions increased: 380 | Existing positions reduced: 356

22% less call options, than puts

Call options by funds: $974M | Put options by funds: $1.24B

Holders
1,014
Holders Change
+22
Holders Change %
+2.22%
% of All Funds
25.28%
Holding in Top 10
38
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+65.22%
% of All Funds
0.95%
New
99
Increased
380
Reduced
356
Closed
68
Calls
$974M
Puts
$1.24B
Net Calls
-$269M
Net Calls Change
-$87M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$513M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$310M
3
Ameriprise
Ameriprise
Minnesota
+$178M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$167M
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$133M

Top Sellers

1
BlackRock
BlackRock
New York
-$344M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$206M
3
Renaissance Technologies
Renaissance Technologies
New York
-$190M
4
SIG
Senator Investment Group
New York
-$136M
5
Citadel Advisors
Citadel Advisors
Florida
-$119M
Name Holding Trade Value Shares
Change 		Change in
Stake
CB
851
Community Bank
New York
$250K – – –
HAG
852
HighPoint Advisor Group
Illinois
$249K +$296 +1 +0.1%
PTC
853
Private Trust Company
Ohio
$248K +$9.18K +31 +4%
SFS
854
Sowell Financial Services
Arkansas
$247K +$296 +1 +0.1%
BTIS
855
BB&T Investment Services
North Carolina
$245K -$28.4K -96 -11%
BL
856
BCWM LLC
Kansas
$245K – – –
CAM
857
Close Asset Management
United Kingdom
$242K – – –
SIM
858
SSI Investment Management
California
$240K -$1.48K -5 -0.6%
CCM
859
Coldstream Capital Management
Washington
$239K +$226K +762 New
KWM
860
Kingsview Wealth Management
Oregon
$239K +$226K +762 New
GC
861
Gilbert & Cook
Iowa
$238K -$143K -484 -39%
AWM
862
Altavista Wealth Management
North Carolina
$238K +$225K +760 New
SPC
863
Sigma Planning Corp
Michigan
$238K +$225K +760 New
MSAM
864
Moloney Securities Asset Management
Missouri
$233K – – –
MMPW
865
Mitchell McLeod Pugh & Williams
Alabama
$230K +$218K +735 New
MC
866
Moors & Cabot
Massachusetts
$228K +$215K +725 New
NAM
867
North American Management
Massachusetts
$227K -$7.7K -26 -3%
EIA
868
Edgemoor Investment Advisors
Maryland
$227K +$215K +725 New
VCM
869
Violich Capital Management
California
$227K +$215K +725 New
SS
870
Sunbelt Securities
Texas
$226K +$214K +723 New
First Manhattan
871
First Manhattan
New York
$225K – – –
BL
872
Balentine LLC
Georgia
$224K +$62.8K +212 +42%
PFS
873
Prospera Financial Services
Texas
$223K +$210K +709 New
ED
874
Exane Derivatives
France
$222K +$187K +632 +810%
AC
875
Abbrea Capital
California
$222K +$210K +710 New
33 34
35
36 37

BIIB Hedge Fund Activity: Q3 2017 in Review

1,014 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q3 2017, worth a combined $59B — up 16% from $50.9B a quarter earlier.

Buyers outnumbered sellers: 99 funds opened new BIIB positions and 68 closed out — a net gain of 31 holders — while 380 added to existing stakes and 356 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $513M. The largest seller was BlackRock, cutting an estimated $344M.

  • 1,014 institutional investors held Biogen (BIIB) as of Q3 2017, up from 992 in Q2 2017.
  • Funds reported $59B of Biogen stock for Q3 2017, up 16% quarter-over-quarter.
  • 99 funds opened new Biogen positions in Q3 2017 and 68 closed out, a net change of +31 holders.
  • The largest Biogen buyer in Q3 2017 was T. Rowe Price Associates, an estimated $513M added.
  • The largest Biogen seller in Q3 2017 was BlackRock, an estimated $344M sold.

Based on aggregated 13F filings for Q3 2017.